Media coverage about UnitedHealth Group (NYSE:UNH) has been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. UnitedHealth Group earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave media stories about the healthcare conglomerate an impact score of 46.7579573387063 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Here are some of the news articles that may have effected Accern’s analysis:
- UnitedHealth Group Supporting People Affected by Mass Shooting at Santa Fe High School (bizjournals.com)
- Dominant Hedge Fund Buys in Q1? Health Care: 13F (finance.yahoo.com)
- United Health Foundation and Climb Wyoming Announce New $1 Million Partnership to Develop Innovative Social Support Programs (finance.yahoo.com)
- New Report on Senior Health Shows Rural Health Disparities Persist, Suicide Rates Are Up (finance.yahoo.com)
- $55.99 Billion in Sales Expected for UnitedHealth Group (UNH) This Quarter (americanbankingnews.com)
A number of brokerages have recently commented on UNH. Sanford C. Bernstein set a $275.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Wednesday, April 18th. Piper Jaffray reissued a “buy” rating and issued a $270.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 18th. Credit Suisse Group lifted their price objective on shares of UnitedHealth Group from $260.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, April 18th. JPMorgan Chase lifted their price objective on shares of UnitedHealth Group to $266.00 and gave the company an “overweight” rating in a research report on Wednesday, April 18th. Finally, Zacks Investment Research raised shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a research report on Thursday, April 19th. Two research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $253.70.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 EPS for the quarter, topping the consensus estimate of $2.91 by $0.13. The business had revenue of $55.19 billion during the quarter, compared to the consensus estimate of $54.90 billion. UnitedHealth Group had a net margin of 5.41% and a return on equity of 22.06%. UnitedHealth Group’s revenue was up 13.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.37 EPS. sell-side analysts forecast that UnitedHealth Group will post 12.61 EPS for the current year.
In other UnitedHealth Group news, Director Richard T. Burke sold 10,400 shares of UnitedHealth Group stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $229.87, for a total value of $2,390,648.00. Following the completion of the sale, the director now owns 1,781,657 shares in the company, valued at approximately $409,549,494.59. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Larry C. Renfro sold 22,184 shares of UnitedHealth Group stock in a transaction dated Thursday, March 15th. The stock was sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the completion of the sale, the insider now owns 173,229 shares of the company’s stock, valued at approximately $39,659,047.26. The disclosure for this sale can be found here. Insiders have sold a total of 72,019 shares of company stock valued at $16,550,733 in the last ninety days. 0.87% of the stock is currently owned by insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.